The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Neuropathic Pain Market Size, Share & Trends Analysis Report By Drug Class, (Anticonvulsants, Antidepressants), By Indication (Diabetic Peripheral Neuropathy, Postherpetic Neuralgia), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global neuropathic pain market size was estimated at USD 8.53 billion in 2025 and is projected to reach USD 15.23 billion by 2033, growing at a CAGR of 7.58% from 2026 to 2033. The neuropathic pai...
April 2026
150 pages
Global Crohn’s Disease Market - 2026-2033
US$ 3,400.00
Global Crohn’s Disease Market reached USD 14.6 billion in 2025 and is expected to reach USD 21.8 billion by 2033, growing with a CAGR of 6.50% during the forecast period 2026-2033. The Global Crohn’s...
April 2026
48 pages
Myasthenia Gravis Therapeutics Market - 2026-2033
US$ 3,400.00
Myasthenia Gravis Therapeutics Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Myasthenia Gravis Therapeutics Market emerges as a key focus in DataM Intelligence lat...
April 2026
56 pages
Palmar Fibromatosis Market - 2026-2033
US$ 3,400.00
Palmar Fibromatosis Market reached US$ 4.58 billion in 2025 and is expected to reach US$ 6.65 billion by 2033, growing with a CAGR of 4.80% during the forecast period 2026-2033. The Palmar Fibromatosi...
April 2026
45 pages
Systemic Sclerosis Market - 2025-2033
US$ 3,400.00
Systemic Sclerosis Market reached US$ 2,384.73 Million in 2024 and is expected to reach US$ 4,132.66 Million by 2033, growing with a CAGR of 6.40% during the forecast period 2026-2033. The Systemic Sc...
April 2026
44 pages
Diffusive Alveolar Hemorrhage Treatment Market - 2026-2033
US$ 3,400.00
Diffusive Alveolar Hemorrhage Treatment Market reached US$ 636.19 million in 2025 and is expected to reach US$ 1,048.37 million by 2033, growing with a CAGR of 6.60% during the forecast period 2026-20...
April 2026
65 pages
Antiulcerant Drugs Market - 2026-2033
US$ 3,400.00
Antiulcerant Drugs Marketis is growing with a CAGR of 4.50% during the forecast period 2026-2035. The Antiulcerant Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...
April 2026
44 pages
Irritable Bowel Syndrome Treatment Market - 2026-2033
US$ 3,400.00
Irritable Bowel Syndrome Treatment Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Irritable Bowel Syndrome Treatment Market emerges as a key focus in DataM Intellig...
April 2026
60 pages
Metachromatic leukodystrophy Treatment Market - 2024-2031
US$ 3,400.00
Metachromatic leukodystrophy Treatment Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The Metachromatic leukodystrophy Treatment Market emerges as a key focus in DataM...
April 2026
64 pages
Acute Renal Failure Therapeutics Market - 2026-2033
US$ 3,400.00
Acute Renal Failure Therapeutics Market reached US$ 6.60 billion in 2025 and is expected to reach US$ 13.05 million by 2033, growing with a CAGR of 8.90% during the forecast period 2026-2033. The Acut...
April 2026
58 pages
